BackNanobac Pharmaceuticals Overview

Nanobac Pharmaceuticals Cost of Revenue

Cost of Revenue analysis for NNBP.

Quarterly Cost of Revenue

$3690.00
↑ 426.39% YoY

As of Dec 31, 2007

Annual Cost of Revenue (TTM)

$14519.00
↓ 81.81% YoY

Trailing 12 months ending Dec 31, 2007

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin